Skip to main content

Published locations for CML-CP: Long-term benefit vs. risk of frontline nilotinib vs. imatinib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CML-CP: Long-term benefit vs. risk of frontline nilotinib vs. imatinib

User login

  • Reset your password
  • /content/cml-cp-long-term-benefit-vs-risk-frontline-nilotinib-vs-imatinib
  • /hematology-oncology/article/235800/cml/cml-cp-long-term-benefit-vs-risk-frontline-nilotinib-vs